Transdermal Delivery Offer for Low Dose Acetylsalicylic Acid

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2016, Vol 1, Issue 1

Abstract

The use of Acetyl Salicylic Acid (ASA) in the secondary prevention of cardio vascular diseases is well known. Orally administered ASA is rapidly metabolized to its principal metabolite Salicylic Acid (SA) in the gastrointestinal fluids, during absorption in the intestine and liver. ASA, and not its hydrolysis product SA, which exhibits antithrombotic activity. Transdermal delivery of acetylsalicylic acid is a safe and convenient alternative, especially during long-term use. The goal of present study was to design transdermal delivery system, using Eudragit E100 weak organic acid and plasticizer. The influence of different dissolution medium for preparation of model systems, the type and amount of cross-linking agents and plasticizer on the release of acetylsalicylic acid was investigated. Matrix systems were prepared by solvent casting method. The dissolution study was carried out in water for 72 hours by disk assembly method paddle and in-vitro release of acetylsalicylic acid from loaded model systems was studied. Quantitative determination of released acetylsalicylic acid by UV spectroscopy at wavelength of 265 nm was made. Significantly sustained release show systems prepared by using water as dissolution medium, MA, like cross linking agent, PEG400 like plasticizer.

Authors and Affiliations

Voycheva C* and Tsonou MM

Keywords

Related Articles

β-Carbonic Anhydrase as a Target for Eradication of Mycobacterium tuberculosis

Infectious diseases are among the most danger, and deadly afflictions that human societies suffering from there. One of the common re-emerged infectious diseases is tuberculosis (TB). The causative pathogen for this dise...

Diclofenac Sodium Loaded Nanosized Ethosomes: An Investigation on Z-Average, Polydispersity and Stability

Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID). Oral therapy with NSAID is always associated with several side effects such as gastric bleeding, and ulceration. The purpose of this work was to explor...

Advances in Anticancer & Marine Drug Research An Overview

Out of earth’s total surface area, more than 70% is covered with marine/salty water. World oldest, most revered & holy texts, the Vedas, term the Ocean as ‘Ratnakar’, or the bestower of immense riches. From times immemor...

Detonation Nanodiamonds: Opportunity for Pharmaceutical and Medical Application

Detonation nanodiamonds have 4-5 nm size primary particles, stable inert core, high surface area and tunable surface structures. They are very attractive from pharmaceutical point of view as a drug delivery vehicle. Nitr...

Drug-Related Problems in Hypertensive Patients with Multiple Comorbidities

Hypertensive patients with multiple comorbidities often received multiple medications to achieve target blood pressure and to treat other comorbidities which can lead to the occurrence of drug-related problems (DRP). The...

Download PDF file
  • EP ID EP745749
  • DOI 10.23880/oajpr-16000103
  • Views 2
  • Downloads 0

How To Cite

Voycheva C* and Tsonou MM (2016). Transdermal Delivery Offer for Low Dose Acetylsalicylic Acid. Open Access Journal of Pharmaceutical Research, 1(1), -. https://europub.co.uk/articles/-A-745749